Izicelo ezininzi ze-paclitaxel kwindawo yonyango lwe-tumor

I-Paclitaxel lichiza elinamandla le-anticancer eliye laba yinxalenye ebalulekileyo yonyango lomhlaza wekliniki ngenxa yendlela ekhethekileyo kunye neenzuzo ezininzi zonyango.Ichiza ekuqaleni lalibekwe lodwa kumthi we-Pacific yew (Taxus brevifolia) ngo-1971, kwaye emva kweminyaka yophando nophuhliso, liye lasetyenziswa kakhulu kwiindawo ezininzi zomhlaza.Eli phepha liza kwazisa iindawo eziphambili zesicelo zepaclitaxel APIkunye nendima yayo ebalulekileyo kwezi ndawo.

Izicelo ezininzi ze-paclitaxel kwindawo yonyango lwe-tumor

1. Unyango lwe-Ovarian Cancer:

Paclitaxelihlala isetyenziselwa ukunyanga umhlaza wesibeleko.Ingasetyenziswa njengonyango lodidi lokuqala okanye, kunye namanye amachiza, njengonyango olongezelelweyo lomhlaza wesibeleko okwinqanaba eliphezulu.I-Paclitaxel inqanda ngokufanelekileyo ukukhula kunye nokusasazeka kweeseli zomhlaza ngokuphazamisa i-mitosis yeeseli ze-tumor.

2. Unyango loMhlaza wamabele:

Kwizigulane zomhlaza wamabele, i-paclitaxel isoloko isetyenziswa ngokudityaniswa namanye amayeza achasene nomhlaza, ngakumbi kumhlaza webele ophambili okanye ophindaphindiweyo.Kuyanceda ukunciphisa ubungakanani bethumba kunye nokuphucula ukusebenza konyango.

3. Unyango loMhlaza wemiphunga:

Umhlaza wemiphunga weseli engeyiyo encinci (NSCLC) luhlobo oluxhaphakileyo lomhlaza wemiphunga, kwaye i-paclitaxel isetyenziswa ngokubanzi njengonyango lokuqala okanye i-adjuvant ye-NSCLC.Inceda ukunciphisa izinga lokukhula kwamathumba kunye nokuphucula amazinga okusinda.

4. Unyango lomhlaza womlomo wesibeleko:

I-Paclitaxel isetyenziswa ngokubambisana ne-Cisplatin kunyango lomhlaza womlomo wesibeleko, rhoqo njengenxalenye yonyango lwe-radiation adjuvant.Olu nyango ludityanisiweyo luphucule kakhulu izinga lokusinda kwezigulane ezinomhlaza womlomo wesibeleko.

5. Unyango lomhlaza wesisu:

I-Paclitaxel ngamanye amaxesha isetyenziswa kunyango lwesisu okanye umhlaza wommizo, ihlala idityaniswa namanye amayeza achasene nomhlaza ukunciphisa ukukhula kwethumba kunye nokusasazeka.

6. Unyango lweProstate Cancer:

I-Paclitaxel ikwanokusetyenziswa kunyango lomhlaza wedlala lesinyi, ngakumbi xa umhlaza usasazeke kwamanye amalungu.Inokulawula ukukhula kwamathumba kunye nokunciphisa iimpawu.

7. Unyango lwePancreatic Cancer:

I-Paclitaxel isoloko isetyenziswa kunye namanye amachiza ukunceda izigulana zisinde kumhlaza wepancreatic.

8. Unyango lwe-non-hodgkin lymphoma:

Paclitaxelikwasetyenziswa kunyango lwe-non-Hodgkin's lymphoma, ehlala idityaniswa namanye amachiza echemotherapy ukunciphisa inqwaba ye-lymphoma.

9. Unyango lwamathumba ebuchotsheni bokuqala okanye bemetastatic:

I-Paclitaxel ngamanye amaxesha isetyenziselwa ukunyanga amathumba engqondo ephambili okanye ye-metastatic, kodwa kufuneka ilawulwe kuwo wonke umqobo wengqondo wegazi, ongenakuwuwela ngokulula.

Ukuqukumbela, i-paclitaxel apis inezicelo ezibalulekileyo kwiindawo ezininzi zomhlaza.Ngokuphazamisa ulwahlulo lweeseli zethumba, luthintela ngokufanelekileyo ukukhula kunye nokusasazeka kweeseli zomhlaza, ukunika ithemba kunye namathuba onyango kwizigulana.Nangona kunjalo,paclitaxelunyango lukwanxulunyaniswa nemiphumo ethile, ngoko ke isicwangciso sonyango kufuneka simiselwe ngokwemeko ethile yesigulane kunye nesincomo sikagqirha sokwandisa ukusebenza kunye nokunciphisa imiphumo emibi.

Qaphela: Iingenelo ezinokusetyenziswa kweli nqaku zifumaneka kuncwadi olupapashiweyo.

I-Yunnan Hande Biotechnology Co., Ltd. iye yagxila kwimveliso ye-paclitaxel iminyaka engama-26, kwaye ingumenzi ozimeleyo wezityalo ezikhutshwe kwi-anti-cancer drug paclitaxel API evunywe yi-United States FDA, i-EDQM yaseYurophu, i-Australia TGA, i-China CFDA. , I-Indiya, iJapan kunye nezinye ii-arhente zelizwe ezilawulayo.I-Yunnan Hande paclitaxel, indawo yokubonelela, ukuthengiswa ngokuthe ngqo kwefektri, wamkelekile ukubuza, 18187887160 (WhatsApp inani elifanayo)


Ixesha lokuposa: Oct-16-2023